Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene. GSL Biotech developed SnapGene to aid the visualization, design, and documentation of DNA cloning, Gibson assembly, mutagenesis, and a growing list of additional molecular biology procedures that now includes synthetic biology. With this collaboration, the constructs designed with SnapGene software can be ordered from Synbio Technologies.
“We are excited to partner with Synbio Technologies,” said Aline Glick, Vice President of Product Management at GSL Biotech. “We think that the combination of SnapGene’s synthetic biology interface and Synbio’s Syno DNA Synthesis Platform will be a powerful toolset for streamlining synthetic biology procedures in labs all over the world.”